Asthma Disease Market Report 2026

Asthma Disease Market Overview

• Asthma Disease market size has reached to $25.93 billion in 2025 • Expected to grow to $33.11 billion in 2030 at a compound annual growth rate (CAGR) of 5% • Growth Driver: Rising Prevalence Of Respiratory Disorders Driving Growth Of The Market Due To Air Pollution • Market Trend: Innovations In Smart Inhaler Technology Transform Asthma Management • North America was the largest region in 2025.

What Is Covered Under Asthma Disease Market?

Asthma disease refers to a chronic inflammatory disorder of the airways characterized by recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night or early in the morning. It involves airflow obstruction that is often reversible either spontaneously or with treatment and is associated with airway hyperresponsiveness to various stimuli such as allergens, exercise, or cold air. The main treatment types of asthma disease are controller medications, rescue medications, biologics, and combination therapy. Controller medications refer to long-term asthma management drugs that are taken daily to prevent asthma symptoms and attacks. The multiple causes of asthma are allergic asthma, non-allergic asthma, exercise-induced asthma, and occupational asthma. The various severities include mild intermittent, mild persistent, moderate persistent, and severe persistent. The several routes of administration include oral, inhaled, intravenous, and others, and are used by various end users such as hospitals, homecare, specialty clinics, and others.

What Is The Asthma Disease Market Growth Forecast?

The asthma disease market size is expected to see steady growth in the next few years. It will grow to $33.11 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to development of novel biologics and combination therapies, increasing adoption of controller medications, expansion of specialty clinics and homecare services, rising patient awareness and education programs, integration of digital health monitoring and smart inhaler technologies. Major trends in the forecast period include rising prevalence of asthma worldwide, increasing adoption of inhalation therapies, growth in biologics and targeted treatments, expansion of homecare and specialty clinics, focus on personalized and precision medicine approaches.

Global Asthma Disease Market Segmentation

1) By Treatment Type: Controller Medications, Rescue Medications, Biologics, Combination Therapy 2) By Cause Of Asthma: Allergic Asthma, Non-Allergic Asthma, Exercise-Induced Asthma, Occupational Asthma 3) By Severity: Mild Intermittent, Mild Persistent, Moderate Persistent, Severe Persistent 4) By Route Of Administration: Oral, Inhaled, Intravenous, Other Route Of Administration 5) By End-Users: Hospitals, Homecare, Specialty Clinics , Other End-Users Subsegments: 1) By Controller Medications: Inhaled Corticosteroids (ICS), Long-Acting Beta-Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Long-Acting Muscarinic Antagonists (LAMA), Methylxanthines 2) By Rescue Medications: Short-Acting Beta-Agonists (SABA), Systemic Corticosteroids, Anticholinergics 3) By Biologics: Anti-IGE Therapy, Anti-IL-5 Therapy, Anti-IL-4/IL-13 Therapy, Anti-TSLP Therapy 4) By Combination Therapy: ICS Or LABA Combinations, ICS Or LABA Or LAMA Combinations, ICS Or LAMA Combinations

What Is The Driver Of The Asthma Disease Market?

The rising prevalence of respiratory disorders is expected to propel the growth of the asthma disease market going forward. Respiratory disorders refer to a group of diseases that affect the lungs and breathing, including chronic obstructive pulmonary disease (COPD), bronchitis, and asthma. The increasing prevalence of respiratory disorders is due to particulate matter and nitrogen oxides irritating and inflaming the airways, leading to breathing difficulties and worsening conditions such as asthma. Respiratory diseases can cause inflammation and airway remodeling, which trigger or worsen asthma symptoms. For instance, in December 2023, according to the National Library of Medicine, a US-based national library, by 2050, chronic obstructive pulmonary disease (COPD) cases in low- and middle-income countries are projected to more than double those in high-income countries, with sub-Saharan Africa expected to see a 59% increase and lead globally in COPD prevalence and cases by 2040. Therefore, the rising prevalence of respiratory disorders is driving the growth of the asthma disease industry.

Key Players In The Global Asthma Disease Market

Major companies operating in the asthma disease market are Pfizer Inc., Merck & Co. Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Cipla Limited

Global Asthma Disease Market Trends and Insights

Major companies operating in the asthma disease market are increasingly focusing on leveraging advanced solutions such as integrated bluetooth enabled sensor inhalers to enhance medication adherence, enable real time usage monitoring, and support personalized disease management. Integrated bluetooth-enabled sensor inhalers are inhalers fitted with digital sensors that sync usage information to a smartphone app, helping people with asthma by tracking medication use, improving adherence through reminders, and providing data that supports better symptom monitoring and management. For instance, in July 2023, Teva Pharmaceutical Industries Limited, an Israel based pharmaceutical company, launched the GoResp Digihaler (budesonide and formoterol) in the UK as the first fully integrated digital inhaler system for asthma disease and chronic obstructive pulmonary disease in Europe. This inhaler, manufactured in Ireland, incorporates built in sensors that detect and record inspiratory flow and usage quality and it pairs with a patient facing app that displays inhalation performance categorized as good, fair, or low or no and enables report sharing with healthcare professionals through email or a clinician dashboard. The app also provides medication reminders to help patients stay consistent with therapy while clinicians gain deeper insight into individual technique and adherence patterns, supporting more tailored interventions.

What Are Latest Mergers And Acquisitions In The Asthma Disease Market?

In January 2024, GSK plc, a UK-based pharmaceutical company, acquired Aiolos Bio Inc. for an undisclosed amount. With this acquisition, GSK aims to strengthen its respiratory treatment portfolio and drive long-term growth by leveraging Aiolos Bio’s innovative therapies and GSK’s global reach to better serve patients worldwide. Aiolos Bio Inc. is a US-based clinical-stage biopharmaceutical company specializing in asthma treatment.

Regional Insights

North America was the largest region in the asthma disease market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Asthma Disease Market?

The asthma disease market consists of revenues earned by entities by providing services such as diagnosis, screening, allergy testing, immunotherapy, education, counselling, and medication management. The market value includes the value of related goods sold by the service provider or included within the service offering. The asthma disease market also includes sales of peak flow meters, spirometers, allergy medications, biologic drugs, air purifiers, humidifiers, smart inhalers, wearable asthma monitors, and allergen-proof bedding. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Asthma Disease Market Report 2026?

The asthma disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the asthma disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.